Histopathological prognostic factors in ANCA-associated glomerulonephritis.
ANCA renal risk score
ANCA-associated vasculitis
End-stage kidney disease
Glomerulonephritis
Histopathological classification
Mayo Clinic chronicity score
Prognostic factors
Journal
Autoimmunity reviews
ISSN: 1873-0183
Titre abrégé: Autoimmun Rev
Pays: Netherlands
ID NLM: 101128967
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
15
06
2022
accepted:
07
07
2022
pubmed:
15
7
2022
medline:
18
8
2022
entrez:
14
7
2022
Statut:
ppublish
Résumé
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are a group of multisystemic autoimmune diseases characterized by necrotizing inflammation of small vessels. Kidney involvement is frequent in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), and accounts for a significant proportion of the morbidity and mortality related to these diseases. Despite improvement in therapeutic management of ANCA-glomerulonephritis (ANCA-GN), end-stage kidney disease (ESKD) still occurs in up to 30% of affected patients within 5 years following diagnosis. Thus, identifying patients for whom aggressive immunosuppressive therapy will be more beneficial than deleterious is of great importance. Several clinical, biological and histological factors have been proposed as predictors of ESKD. The kidney biopsy is essential not only for the diagnosis, but also for evaluating renal prognosis. In this review, we discuss the prognostic value of renal lesions at the diagnosis of ANCA-GN by analyzing each compartment of the nephron. We also review existing ESKD risk classification in ANCA-GN and finally propose an example of a standardized pathology report that could be used in routine practice.
Identifiants
pubmed: 35835443
pii: S1568-9972(22)00109-4
doi: 10.1016/j.autrev.2022.103139
pii:
doi:
Substances chimiques
Antibodies, Antineutrophil Cytoplasmic
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103139Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.